Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

NCT02406677 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02406677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02406677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
June 5, 2015
Completion date
October 23, 2017
Enrollment
11,001 (actual)
Sites
272

Conditions

As the registry lists them; a condition with its own page is linked.

cost sharing, acute coronary syndrome